Cargando…

An Open-Access, Interactive Decision-Support Tool to Facilitate Guideline-Driven Care for Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is increasing in incidence and is a leading cause of cancer-related mortality worldwide. Adherence to HCC surveillance guidelines and appropriate treatment triage of liver lesions may improve receipt of curative-intent treatment and improved survival. Late-stage HCC di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wong, Robert J., Jayasekera, Channa, Jones, Patricia, Kanwal, Fasiha, Singal, Amit G., Ahmed, Aijaz, Taglienti, Robert, Younossi, Zobair, Kulik, Laura, Mehta, Neil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822660/ https://www.ncbi.nlm.nih.gov/pubmed/36660470 http://dx.doi.org/10.14740/gr1573

Ejemplares similares

Sofosbuvir-based Regimens with Task Shifting Is Cost-effective in Expanding Hepatitis C Treatment Access in the United States
por: Jayasekera, Channa R., et al.
Publicado: (2017)

Trends in Liver Transplantation in Hepatitis C Virus–Infected Persons, United States
por: Perumpail, Ryan B., et al.
Publicado: (2016)

Expanding Treatment Access for Chronic Hepatitis C with Task-shifting in the Era of Direct-acting Antivirals
por: Yoo, Eric R., et al.
Publicado: (2017)

Patients With Diabetes and Chronic Liver Disease Are at Increased Risk for Overall Mortality: A Population Study From the United States
por: Stepanova, Maria, et al.
Publicado: (2017)

Epidemiology of non-alcoholic fatty liver disease and hepatocellular carcinoma
por: Younossi, Zobair M., et al.
Publicado: (2021)

Assessment of cost of innovation versus the value of health gains associated with treatment of chronic hepatitis C in the United States: The quality-adjusted cost of care
por: Younossi, Zobair M., et al.
Publicado: (2016)

Adding to the evidence base: Effectiveness of hepatocellular carcinoma surveillance in clinical practice
por: Pandya, Prashant, et al.
Publicado: (2017)

The impact of hepatocellular carcinoma diagnosis on patients' health‐related quality of life
por: Verma, Manisha, et al.
Publicado: (2021)

Development and validation of a primary sclerosing cholangitis-specific health-related quality of life instrument: CLDQ-PSC
por: Younossi, Zobair M., et al.
Publicado: (2023)

Barriers to Surveillance for Hepatocellular Carcinoma in a Multicenter Cohort
por: Parikh, Neehar D., et al.
Publicado: (2022)

Importance of fatigue and its measurement in chronic liver disease
por: Gerber, Lynn H, et al.
Publicado: (2019)

Circulating miRNA in patients with non-alcoholic fatty liver disease and coronary artery disease
por: Mehta, Rohini, et al.
Publicado: (2016)

Rising Rate of Liver Transplantation in the Baby Boomer Generation with Non-alcoholic Steatohepatitis in the United States
por: Siddique, Osama, et al.
Publicado: (2017)

An open access medical knowledge base for community driven diagnostic decision support system development
por: Müller, Lars, et al.
Publicado: (2019)

Pediatric Non-Alcoholic Fatty Liver Disease
por: Bush, Haley, et al.
Publicado: (2017)

Nonalcoholic steatohepatitis: global impact and clinical consequences
por: Kabarra, Khaled, et al.
Publicado: (2021)

Expression of NALPs in adipose and the fibrotic progression of non-alcoholic fatty liver disease in obese subjects
por: Mehta, Rohini, et al.
Publicado: (2014)

Gene expression profiles associated with depression in patients with chronic hepatitis C (CH-C)
por: Birerdinc, Aybike, et al.
Publicado: (2012)

Adherence to treatment of chronic hepatitis C: from interferon containing regimens to interferon and ribavirin free regimens
por: Younossi, Zobair M., et al.
Publicado: (2016)

Quality of Care in the Cirrhotic Patient
por: Volk, Michael L, et al.
Publicado: (2016)

Underutilization of Living Donor Liver Transplantation in the United States: Bias against MELD 20 and Higher
por: Perumpail, Ryan B., et al.
Publicado: (2016)

Validation of endogenous reference genes for qRT-PCR analysis of human visceral adipose samples
por: Mehta, Rohini, et al.
Publicado: (2010)

Mortality of NAFLD According to the Body Composition and Presence of Metabolic Abnormalities
por: Golabi, Pegah, et al.
Publicado: (2020)

The Growing Burden of Disability Related to Nonalcoholic Fatty Liver Disease: Data From the Global Burden of Disease 2007‐2017
por: Paik, James M., et al.
Publicado: (2020)

The Growing Burden of Disability Related to Chronic Liver Disease in the United States: Data From the Global Burden of Disease Study 2007‐2017
por: Paik, James M., et al.
Publicado: (2021)

The burden of nonalcoholic fatty liver disease (NAFLD) is rapidly growing in every region of the world from 1990 to 2019
por: Paik, James M., et al.
Publicado: (2023)

A Practical Guideline for Hepatocellular Carcinoma Screening in Patients at Risk
por: Frenette, Catherine T., et al.
Publicado: (2019)

Mortality assessment of patients with hepatocellular carcinoma according to underlying disease and treatment modalities
por: Golabi, Pegah, et al.
Publicado: (2017)

The Texas collaborative center for hepatocellular cancer: Reducing liver cancer mortality in Texas through coordination, collaboration and advocacy
por: Harrison, Ariel C., et al.
Publicado: (2022)

The role of mitochondrial genomics in patients with non-alcoholic steatohepatitis (NASH)
por: Mehta, Rohini, et al.
Publicado: (2016)

Mortality Related to Nonalcoholic Fatty Liver Disease Is Increasing in the United States
por: Paik, James M., et al.
Publicado: (2019)

Non-Invasive markers for hepatic fibrosis
por: Baranova, Ancha, et al.
Publicado: (2011)

Exercise as an intervention for patients with end-stage liver disease: Systematic review
por: Locklear, Cameron T., et al.
Publicado: (2018)

Advances and challenges in the management of advanced fibrosis in nonalcoholic steatohepatitis
por: Sayiner, Mehmet, et al.
Publicado: (2018)

Polymorphisms in the receptor for advanced glycation end-products (RAGE) gene and circulating RAGE levels as a susceptibility factor for non-alcoholic steatohepatitis (NASH)
por: Mehta, Rohini, et al.
Publicado: (2018)

Dietary Risks for Liver Mortality in NAFLD: Global Burden of Disease Data
por: Paik, James M., et al.
Publicado: (2021)

Qualitative analysis of patient-centered decision attributes associated with initiating hepatitis C treatment
por: Zuchowski, Jessica L., et al.
Publicado: (2015)

Diet Satisfaction and Adequate Food Intake in Patients with Chronic Liver Diseases
por: Gerber, Suzannah, et al.
Publicado: (2022)

Variables Associated With Inpatient and Outpatient Resource Utilization Among Medicare Beneficiaries With Nonalcoholic Fatty Liver Disease With or Without Cirrhosis
por: Sayiner, Mehmet, et al.
Publicado: (2017)

Design Guidelines for Database-Driven Internet of Things-Enabled Dynamic Spectrum Access
por: Guimarães, Dayan A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j9db6vunkocr0aa8otfiifalt9